We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-13.64%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$42.3B
AUM Growth
-$25.4B
Cap. Flow
-$18.9B
Cap. Flow %
-44.7%
Top 10 Hldgs %
18.81%
Holding
4,572
New
126
Increased
1,431
Reduced
2,296
Closed
248

Sector Composition

Rank Sector Weight
1 Technology 7%
2 Financials 5.86%
3 Healthcare 5.05%
4 Consumer Discretionary 4.98%
5 Industrials 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALA icon
3726
KALA BIO
KALA
$17.1M
0
SIOX
3727
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.68K ﹤0.01%
211
+23
+12% +$332
KDNY
3728
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.67K ﹤0.01%
126
-509
-80% -$10.2K
FPH icon
3729
Five Point Holdings
FPH
$372M
$1.65K ﹤0.01%
237
-81
-25% -$639
ARL icon
3730
American Realty Investors
ARL
$243M
$1.64K ﹤0.01%
136
+68
+100% +$1.05K
USX
3731
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$1.64K ﹤0.01%
+292
New +$2.45K
VIVS
3732
VivoSim Labs
VIVS
$1.16M
$1.64K ﹤0.01%
7
-7
-50% -$1.76K
AXGN icon
3733
Axogen
AXGN
$2.67B
$1.63K ﹤0.01%
80
-983
-92% -$30.8K
MVIS icon
3734
Microvision
MVIS
$89.7M
$1.63K ﹤0.01%
180
+28
+18% +$394
LAB icon
3735
Standard BioTools
LAB
$312M
$1.62K ﹤0.01%
188
-395
-68% -$3.08K
SNDX icon
3736
Syndax Pharmaceuticals
SNDX
$1.77B
$1.62K ﹤0.01%
364
-87
-19% -$477
BXG
3737
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$1.59K ﹤0.01%
123
-112
-48% -$1.51K
MNTX
3738
DELISTED
Manitex International, Inc.
MNTX
$1.59K ﹤0.01%
280
-195
-41% -$1.51K
ODT
3739
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$1.58K ﹤0.01%
112
-102
-48% -$1.59K
UMH
3740
UMH Properties
UMH
$1.39B
$1.57K ﹤0.01%
133
-1,270
-91% -$17.2K
TPIC
3741
DELISTED
TPI Composites
TPIC
$1.57K ﹤0.01%
64
-446
-87% -$11.3K
YARW
3742
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
0
VATE icon
3743
INNOVATE Corp
VATE
$105M
$1.56K ﹤0.01%
59
-81
-58% -$3.41K
VIA
3744
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$1.56K ﹤0.01%
42
-35
-45% -$1.46K
ORN icon
3745
Orion Group Holdings
ORN
$402M
$1.55K ﹤0.01%
362
-559
-61% -$2.81K
GWRS icon
3746
Global Water Resources
GWRS
$219M
$1.55K ﹤0.01%
153
-163
-52% -$1.7K
OPOF
3747
DELISTED
Old Point Financial
OPOF
$1.55K ﹤0.01%
71
+9
+15% +$232
OFED
3748
DELISTED
Oconee Federal Financial Corp.
OFED
$1.54K ﹤0.01%
62
+25
+68% +$636
TNAV
3749
DELISTED
Telenav Inc.
TNAV
$1.52K ﹤0.01%
375
-727
-66% -$3.13K
IRMD icon
3750
iRadimed
IRMD
$1.12B
$1.52K ﹤0.01%
62
-52
-46% -$1.4K

Similar funds

BNP Paribas Financial Markets's Q4 2018 Portfolio in Review

As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 9.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.

  • BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
  • BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
  • BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
  • BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
  • BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
  • BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
  • BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.